Use of botulinum toxin type A in neuro-ORL;Indications de la neurotoxine botulique A en neuro-ORL

Annales de Readaptation et de Medecine Physique

Volumn 46, Issue 6, 2003, Pages 375-379

  Perie S ^a   Lacau St Guily, J ^a  

^a HÔPITAL TENON   (France)

Author keywords

Electromyography; Frey's syndrome; Laryngeal dystonia; Oromandibular dystonia; Spasmodic dysphonia

Indexed keywords

BOTULINUM TOXIN A; EMLA;

BREATHING DISORDER; DYSPHAGIA; DYSTONIA; HUMAN; LARYNX MUSCLE; LOWER ESOPHAGUS SPHINCTER; MASTICATORY MUSCLE; MUSCLE CONTRACTION; PHONATION; REVIEW;

EID: 0041928167     PISSN: 01686054     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6054(03)00127-2     Document Type: Article

References (18)

1. Blitzer A, Brin MF. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg 1997;116:328-30.
2. Blitzer A, Brin MF, Greene PE, Fahn S. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 1989;98:93-7.
3. Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12 years experience in more than 900 patients. Laryngoscope 1998;10:1435-41.
4. Brin MF, Blitzer A, Fahn S, Gould W, Lovelace RE. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox). Mov Disord 1989;4:287-96.
5. Brin MF, Blitzer A, Stewart C, Fahn S. Treatment of spasmodic dysphonia (laryngeal dystonia) with local injections of botulinum toxin: review and technical aspects. In: Blitzer A, Sasaki CT, Fahn S, Brin A, Harris KS, editors. Neurological disorders of the larynx. New York, NY: Thieme Publishers; 1992. p. 214-28.
6. Drobik C, Laskawi R. Frey's syndrome: treatment with botulinum toxin. Acta Oto-laryngol (Stockh) 1995;115:459-61.
7. Fève A, Angelard B, Fénelon G, Logak M, Guillard A, Lacau St Guily J. Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin. Mov Dis 1993;8:217-9.
8. Fève A, Angelard B, Lacau St Guily J. Laryngeal tardive dyskinesia. J Neurol 1995;242:455-9.
9. Grillone GA, Blitzer A, Brin MF, Annino DJ, Saint-Hilaire MH. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A. Laryngoscope 1994;104:30-2.
10. Klap P, Marion MH, Perrin A, Fresnel-Elbaz E, Cohen M. Indication de la toxine botulique en laryngologie. Revue Laryngologie 1993;114:281-7.
11. Laccourreye O, Akl E, Gutierrez-Fonseca R, Garcia D, Brasnu D, Bonan B. Gustatory sweating (Frey syndrome) after intracutaneous injection of Botulinum toxin type A. Arch OtoLaryngol Head Neck Surg 1999;125:283-6.
12. Lovelace RE, Blitzer A, Ludlow CL. Clinical laryngeal electromyography. In: Blitzer A, Sasaki CT, Fahn S, Brin A, Harris KS, editors. Neurological disorders of the larynx. New York, NY: Thieme Publishers; 1992. p. 66-81.
13. Ludlow CL, Naunton RF, Sedory SE, Schulz GM, Hallett M. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurol 1988;38:1220-5.
14. Marsden CD, Sheehy MP. Spastic dysphonia. Meige disease and torsion dystonia. Neurology 1982;32:1202.
15. Meige H. Remarques personnelles sur les torticolis spasmodiques. Rev Neurol (Paris) 1929;339:1013-21.
16. Ravich WJ. Botulinbum toxin for UES dysfunction: therapy or poison. Dysphagia 2001;16:168-70.
17. Schneider I, Thumfart WF, Pototschnig HE, Eckel. Treatement of dysfunction of the cricopharyngeal muscle with botulinum toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol 1994;103:31-5.
18. Shaw GY, Searl JP. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia 2001;16:161-7.